ea0020p285 | Clinical case reports and clinical reports | ECE2009
Kaldrymides Philippos
, Kostoglou-Athanassiou Ifigenia
, Goudouvas Anastasios
, Veniou Eirini
, Bakola Theodosia
, Agelopoulou Anastasia
, Thomas Dimitrios
, Ziras Nikolaos
Medullary thyroid carcinoma is an uncommon malignancy of hereditary and sporadic presentation. Mutations in the RET-protooncogene are involved in the pathogenesis of >50% of the sporadic cases. Currently, there is no effective treatment for metastatic medullary thyroid carcinoma. The aim was to present a case of metastatic medullary thyroid carcinoma that was treated by the administration of sorafenib, a multiple kinase inhibitor.A patient, female ag...